Bengaluru, Oct 29
Jubilant Life Sciences Ltd posted Rs.51 crore net profit for second quarter of this 2015-16 as against Rs.217 crore in the same period last year, registering 77 percent decline on standalone basis.
In a regulatory filing to the Bombay Stock Exchange (BSE), the pharma major said its income remained flat at Rs.746 crore in quarter under review as against Rs.751 crore in same period year ago on standalone basis.
On consolidated basis, the company turned into black, with Rs.116 crore net profit in Q2 from a net loss of Rs.94 crore year ago.
while total income grew five percent to Rs.1,468 crore in Q2 from Rs.1,398 crore year ago.
1. Content is from IANS
- Pentagon cancels aid to Pakistan over record on militants - September 2, 2018
- The curious case of Tamil Nadu’s opposition to NEET - September 4, 2017
- If 2.6 Billion People Go To War: India vs. China - July 22, 2017